
Glidum MF 4mg/1000mg Tablet SR
Marketer
Knoll Pharmaceuticals Ltd
Salt Composition
Glimepiride (4mg) + Metformin (1000mg)
Overview Glidum MF 4mg/1000mg Tablet SR
DiabetaComb 4mg/1000mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. DiabetaComb 4mg/1000mg ER Tablets should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan involving a healthy diet, regular physical activity, and weight management, as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its hypoglycemic effect. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Glidum MF 4mg/1000mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glidum MF 4mg/1000mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glidum MF 4mg/1000mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with food.
Common Side effects of Glidum MF 4mg/1000mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glidum MF 4mg/1000mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. The Glidum MF 4mg/1000mg Sustained-Release tablet should be taken with a meal.
How Glidum MF 4mg/1000mg Tablet SR works:
Glimepiride/Metformin 4mg/1000mg extended-release tablets (Glidum MF) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, retarding intestinal glucose uptake, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glidum MF 4mg/1000mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glidum MF 4mg/1000mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingUNSAFE
Extended-release Glidum MF 4mg/1000mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Exercise caution when administering Glidum MF 4mg/1000mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not take Glidum MF 4mg/1000mg SR tablets. Physician consultation is recommended. Close monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glidum MF 4mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glidum MF 4mg/1000mg Tablet SR :
Should you forget a Glidum MF 4mg/1000mg SR tablet, take it immediately. If your next dose is imminent, however, omit the missed tablet and resume your usual dosing regimen. Never take more than the prescribed amount.
Facts to Know About Glidum MF 4mg/1000mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
